Science in a Bigger Europe

Click for larger version (58K) Scientists throughout Europe are busy clicking on a "Find a Partner" link. They are not seeking romance. A typical proposal: "Seeking partners to study the influence of genetic and environmental factors on human morphofunctional status." The partner search service on the European Union's Framework 6 Programme (FP6) Web site (www.cordis.lu/fp6) is linking scientists seeking the transnational partners required for their projects to be eligible for FP6 fundin

Written byAndrew Scott
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Scientists throughout Europe are busy clicking on a "Find a Partner" link. They are not seeking romance. A typical proposal: "Seeking partners to study the influence of genetic and environmental factors on human morphofunctional status."

The partner search service on the European Union's Framework 6 Programme (FP6) Web site (www.cordis.lu/fp6) is linking scientists seeking the transnational partners required for their projects to be eligible for FP6 funding. They are chasing their share of the ¤17.5 billion FP6 budget, which has at least 21% earmarked for the life sciences.1 With the European Union set to grow larger, the partner searches are covering new territory.2 On April 16, 10 countries were due to sign the Accession Treaty for EU entry in 2004. Others are in the queue.

A NEW ERA The key aim is to create a huge European Research Area (ERA) in which researchers would move freely across borders and cultural ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies